Opendata, web and dolomites


DosiKit, a first portable field medical device for fast triage of people after external irradiation

Total Cost €


EC-Contrib. €






 DosiKit project word cloud

Explore the words cloud of the DosiKit project. It provides you a very rough idea of what is the project "DosiKit" about.

irradiated    requiring    seasoned    published    potentially    collaborations    ip    founded    loi    expose    cartography    final    israel    nuclear    initiated    giving    minutes    fulfil    young    atomic    radiological    individuals    instrument    body    fto    reached    singapore    sales    people    responders    competencies    starting    triage    biodosimetry    performed    45    market    french    critical    international    hospitals    2024    undergoing    2009    crisis    commercialize    contact    energy    protected    armies    unmet    usa    partial    2022    booster    medical    invented    schedule    nrbc    irradiation    commercial    2014    changer    staff    accident    lack    classify    care    transportable    revenue    uniting    patents    fast    validation    actions    communications    exposed    15    publications    dosikit    survey    dosimetric    game    doctors    scientific    biological    device    emergency    army    exposure    trl6    continued    prototype    radiation    acubens    tools    validated    specialist    experimented    forecasted    regulatory    innovative    worldwide    exercise    business    sme    oral    risk    managers    diagnostic    technological    team    bio    initial    germany    pbi   

Project "DosiKit" data sheet

The following table provides information about the project.


Organization address
postcode: 92160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACUBENS FR (NANTERRE) coordinator 50˙000.00


 Project objective

Acubens was founded in 2014, to develop and commercialize new game-changer medical diagnostic devices around NRBC emergency. Our team gathers young and experimented doctors, and seasoned business managers, uniting their competencies to develop nuclear/radiological/biological innovative transportable biodosimetry devices. Nuclear/radiological accident can expose individuals to radiation, with the need for fast triage of potentially exposed people requiring immediate medical care. There is today a lack of irradiation biodosimetry tools that can be used in the field, by non-specialist staff, giving immediate results and exposure cartography in case of Partial-Body irradiation (PBI). To fulfil this critical unmet need for better initial crisis management, we invented the DosiKit device and fast test (45 minutes) to identify and classify irradiated individuals, directly in the field. This development was initiated in 2009 by the French Atomic Energy Commission within the European Commission program, BOOSTER (‘BiO-dOSimetric Tools for triagE to Responders’), and then continued by Acubens. DosiKit technology is protected by 3 international patents and has reached TRL6 with a prototype validated in a large-scale exercise performed with the French army. Several collaborations are undergoing for biological validation with French research institute and hospitals. Scientific and technical development was published in 3 scientific publications and many international oral communications. A strong contact has established with French, Germany, Israel, US and Singapore armies (LoI). This DosiKit product will be on the market in 2022, starting in Europe and then extending worldwide. Forecasted sales revenue is 15 M€ in 2024. The objectives of this phase 1 SME-Instrument are: (1) the final Biological and Technological validation of the device, (2) IP, FTO, Regulatory and risk assessment studies and (3) a market survey in Europe and USA to schedule our commercial actions.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DOSIKIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DOSIKIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  
lastchecktime (2022-12-01 3:54:45) correctly updated